Geneva, Sept. 23 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000059060) titled 'Exploratory Study to Evaluate the Impact of Prebiotic Intake on the Gut Microbiota and Health Status' on Sept. 11.
Study Type: Interventional
Study Design:
Parallel Randomized
Primary Sponsor: Meiji Holdings Co., Ltd.
Condition:
Healthy adults
Intervention:
Oral ingestion of oligosaccharide for 4 weeks
Oral ingestion of placebo for 4 weeks
Recruitment Status: Not Recruiting
Phase: Not applicable
Date of First Enrollment: 2025/09/11
Target Sample Size: 60
Countries of Recruitment:
Japan
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067555
Published ...